PALO ALTO, Calif., Aug. 2 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it will report its second quarter 2010 financial results on Tuesday, August 10, 2010. Jazz Pharmaceuticals will host an investor conference call and live webcast to give a company update, as well as to discuss financial results and guidance, on August 10, 2010, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time.
The live webcast and press release may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.
Investors may also participate in the conference call by dialing 866-770-7125 in the U.S., or 617-213-8066 outside the U.S., and entering passcode 89022514.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see www.jazzpharmaceuticals.com.
|SOURCE Jazz Pharmaceuticals, Inc.|
Copyright©2010 PR Newswire.
All rights reserved